The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ALLERGAN PLC SHS G0177J108 3,646 15,000 SH   SOLE   15,000 0 0
AMARIN CORP PLC SPONS ADR NEW 023111206 1,814 450,000 SH   SOLE   450,000 0 0
CRYOLIFE INC COM 228903100 3,990 200,000 SH Put SOLE   200,000 0 0
DEPOMED INC COM 249908104 1,074 100,000 SH Call SOLE   100,000 0 0
DEPOMED INC COM 249908104 5,907 550,000 SH   SOLE   550,000 0 0
FIBROCELL SCIENCE INC COM PAR 315721308 40 10,000 SH Call SOLE   10,000 0 0
FLUIDIGM CORP DEL COM 34385P108 606 150,000 SH Call SOLE   150,000 0 0
FLUIDIGM CORP DEL COM 34385P108 1,456 360,500 SH   SOLE   360,500 0 0
GILEAD SCIENCES INC COM 375558103 4,247 60,000 SH Call SOLE   60,000 0 0
GILEAD SCIENCES INC COM 375558103 5,309 75,000 SH   SOLE   75,000 0 0
IMMUNOMEDICS INC COM 452907108 883 100,000 SH Call SOLE   100,000 0 0
NOVELION THERAPEUTICS INC COM NEW 67001K202 7,674 831,440 SH   SOLE   831,440 0 0
PFIZER INC COM 717081103 8,398 250,000 SH   SOLE   250,000 0 0
PROSHARES TR ULTSH NASD BIOT 74347B789 606 25,000 SH   SOLE   25,000 0 0
PROSHARES TR ULTSH NASD BIOT 74347B789 4,852 200,000 SH Call SOLE   200,000 0 0
PROSHARES TR II VIX SHORT TERM F 74347W262 2,658 250,000 SH Call SOLE   250,000 0 0
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADR 881624209 2,492 75,000 SH   SOLE   75,000 0 0